NTRK1 and nervous system disorder: AMI may exert neurotrophic effects in primary cortical neurons by activation of a Trk/MAPK signaling pathway and possibly alleviating the loss of synaptic connections under conditions where atrophy and loss of synaptic connections may contribute to progression of neurological diseases (O’Neill et al., 2016).